• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Glenmark Pharmaceuticals Limited — Updates, 29-05-2026: Press Release

    29-05-2026 | 09:59 pm

    Glenmark reported Q4 revenue of INR 3,770.6 Cr (+15.8% YoY) and FY26 revenue of INR 16,982.5 Cr (+27.5% YoY). Secured a landmark AbbVie deal for ISB 2001, including USD 700 million upfront. Strengthened US generics and saw RYALTRIS® sales grow >50%. Monroe facility cleared for manufacturing. Settled antitrust for USD 29.628 million.

    No comments yet. Be the first to comment!

    All announcements from Glenmark Pharmaceuticals Limited